Cleveland Clinic NanoMedicine Summit 2004 to Examine the Big Potential of Tiny Technology

Oct. 25-26 Event will Discuss How to Use Nanotechnology

to Improve Patient Care

Sep 22, 2004, 01:00 ET from The Cleveland Clinic Foundation

    CLEVELAND, Sept. 22 /PRNewswire/ -- The Cleveland Clinic Lerner Research
 Institute will host a national summit in October to explore innovative
 strategies for translating nanotechnology, the field of tiny technology, into
 biomedical research and clinical devices to benefit patient care.
     The Cleveland Clinic NanoMedicine Summit 2004 will take place Oct. 25-26
 at the InterContinental Hotel and MBNA Conference Center Cleveland. The event
 will kickoff Cleveland NANO Week and is being presented in collaboration with
 Case Western Reserve University, Cornell University and the Maple Fund. The
 summit will offer insight from top nanotechnology experts and draw biomedical
 researchers and leading practitioners in the fields of cardiology, neurology,
 oncology and orthopaedics.
     Derek Raghavan, M.D., Ph.D., chairman of The Cleveland Clinic Taussig
 Cancer Center, and Harold Craighead, co-director of the Nanotechnology Center
 at Cornell University, are the event's plenary speakers. The two-day event
 will include two lunchtime forums highlighting the perspective of high-profile
 industry experts on the role of nanotechnology in their fields.
     "This summit will bring together top nanoscientists from around the
 country and leading biomedical researchers and clinician investigators to
 explore the feasibility of applying nanotechnology solutions to fill unmet
 clinical needs," said Shuvo Roy, Ph.D., a biomedical engineer and researcher
 at The Cleveland Clinic Lerner Research Institute. Dr. Roy is leading the
 summit's organizing committee. "This is a great show of the capabilities of
 nanotechnology at The Cleveland Clinic and throughout the biotech world."
     Nanotechnology combines chemistry, physics, and engineering to develop new
 materials and devices by manipulating matter at the molecular scale to produce
 the precise structures needed. The materials and devices have dimensions that
 are smaller than a few hundred nanometers, or billionths of a meter. The field
 promises to offer revolutionary new opportunities in healthcare technology.
     The Oct. 25 lunchtime panel will cover nanotechnology in relation to
 medical devices. Panelists will include Youseph Yazdi, corporate director of
 science and technology for Johnson & Johnson; Joseph Smith, chief medical
 officer of cardiac rhythm management for Guidant Corp.; Michael Helmus, vice
 president of advanced biomaterials and corporate research for Boston
 Scientific Corp.; and Paul Citron, vice president of science and technology
 for Medtronic Inc.
     "The Cleveland Clinic NanoMedicine Summit is unique in focusing more
 closely on the clinical applications and clinicians than other nanotechnology
 meetings," said Mr. Yazdi of Johnson & Johnson. "This focus is critical in
 providing a reality check in this rapidly developing field."
     The Oct. 26 lunchtime panel will focus on nanotechnology in relation to
 the pharmaceutical industry. In addition to Mr. Yazdi, panelists will include
 Mostafa Analoui, senior director and global head of computational medicine and
 clinical technology for Pfizer Global Research and Development; Stephen de
 Laszlo, director of strategic platform technologies and external scientific
 affairs for Merck Research Laboratories; and Margaret Blohm of GE Medical.
     Expert presentations and panel forums at the summit will highlight state-
 of-the-art biomedical nanotechnology, discuss specifications for nanoscale
 tools for biomedical research, and identify unmet clinical needs ripe for
 nanobiotechnology solutions. Attendees will have opportunities to network at
 two receptions where exhibitors will also demonstrate the latest
 nanotechnoloqy equipment for biomedical research and clinical applications.
     Topics to be covered at the summit include:
      * Nanotechnology concepts relevant to clinical medicine and biomedical
      * Current research tools for molecular biology -- noninvasive imaging,
        tissue engineering, neuroscience, clinical pathology and molecular
      * Unmet clinical needs in neurological, cardiovascular, orthopaedic and
        oncologic medicine.
      * Nanoscale technologies including quantum dots, biosensors, cell
        sorters, drug delivery, biomimetic scaffolds, AFM manipulation, genetic
        sequencing, carbon nanotubes, nanopatterned substrates and cell
     Upon attending the summit, attendees will be able to:
      * Recognize terms and concepts that characterize current nanotechnology
      * Distinguish between top-down and bottom-up nanofabrication strategies.
      * Identify nanoscale tools under development that will enhance biomedical
      * Understand potential of nanobiotechnology to address unmet clinical
      * Determine high-impact opportunities for nanotechnology in medicine.
      * Develop strategies to translate nanotechnology into clinical practice.
     Physicians attending the summit will be able to earn up to 15 Type 1 CME
 (continuing medical education) credits towards the AMA Physicians Recognition
 Award. Category 2 CME credits for the American Osteopathic Association are
 also available.
     The Lerner Research Institute is home to The Cleveland Clinic's basic
 research departments comprising approximately 130 principal investigators.
 With total annual research expenditures exceeding $150 million from federal
 agencies, non-federal societies and associations and endowment funds, the
 Lerner Research Institute is the fifth largest research institute in the
 United States.
     The Cleveland Clinic Foundation, located in Cleveland, Ohio, is a
 not-for-profit multispecialty academic medical center that integrates clinical
 and hospital care with research and education. The Cleveland Clinic was
 founded in 1921 by four renowned physicians with a vision of providing
 outstanding patient care based upon the principles of cooperation, compassion
 and innovation. U.S. News & World Report consistently names The Cleveland
 Clinic as one of the nation's best hospitals in its annual "America's Best
 Hospitals" survey. Approximately 1,200 full-time salaried physicians at The
 Cleveland Clinic and Cleveland Clinic Florida represent more than 100 medical
 specialties and subspecialties. In 2003, patients came for treatment from
 every state and from nearly 90 countries. The Cleveland Clinic website address
 is .

SOURCE The Cleveland Clinic Foundation